Approval · Notice of Compliance 12841 · 2011
RESOTRAN: Notice of Compliance 12841
Issued December 7, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12841
- Date
- December 7, 2011
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Enterokinetic Agent
Products in this notice
Medicinal ingredients
- PRUCALOPRIDE SUCCINATE 1 MG per TAB
- PRUCALOPRIDE SUCCINATE 2 MG per TAB